NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

:D Chris, you're my new favorite poster by a mile!

What I think is the trial will add MOS to PFS as a primary endpoint. MOS is what matters here the FDA knows it Biden knows it. --md1225

Okay, so just slide it on up there to primary, OS? No big deal, no need to change anything else? That's awesome, I feel so much better now.

And good thing Biden don't mind ;) ;) eh? eh?! ;) ;) ;)

We certainly do not need to raise the enrollment numbers the MOS will beat Temodar by a year minimum. --md

Sweet!!